4//SEC Filing
Kuhlmann Shirley R. 4
Accession 0001062993-24-003167
CIK 0001267565other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:14 PM ET
Size
9.9 KB
Accession
0001062993-24-003167
Insider Transaction Report
Form 4
Kuhlmann Shirley R.
EVP and General Counsel
Transactions
- Award
Common Stock
2024-02-12+43,400→ 162,918 total - Award
Common Stock
2024-02-12+33,247→ 196,165 total - Tax Payment
Common Stock
2024-02-12$33.70/sh−21,146$712,620→ 175,019 total - Tax Payment
Common Stock
2024-02-12$33.70/sh−10,610$357,557→ 164,409 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 33,247 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001734919
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:14 PM ET
- Size
- 9.9 KB